MX9306295A - Composiciones farmaceuticas para tratar sintomas de resfriado. - Google Patents
Composiciones farmaceuticas para tratar sintomas de resfriado.Info
- Publication number
- MX9306295A MX9306295A MX9306295A MX9306295A MX9306295A MX 9306295 A MX9306295 A MX 9306295A MX 9306295 A MX9306295 A MX 9306295A MX 9306295 A MX9306295 A MX 9306295A MX 9306295 A MX9306295 A MX 9306295A
- Authority
- MX
- Mexico
- Prior art keywords
- cold
- pharmaceutical compositions
- treat symptoms
- symptoms
- treat
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Una composición farmacéutica para tratar síntomas de resfriado caracterizada porque comprende un compuesto activo y 3-1-mentoxipropano-1,2-diol.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US95501392A | 1992-10-09 | 1992-10-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9306295A true MX9306295A (es) | 1994-04-29 |
Family
ID=25496254
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9306295A MX9306295A (es) | 1992-10-09 | 1993-10-08 | Composiciones farmaceuticas para tratar sintomas de resfriado. |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0662840A1 (es) |
JP (1) | JPH08502288A (es) |
AU (1) | AU678561B2 (es) |
CA (1) | CA2146637C (es) |
MX (1) | MX9306295A (es) |
NZ (1) | NZ256346A (es) |
WO (1) | WO1994008551A2 (es) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2160874C (en) * | 1993-04-30 | 1999-05-11 | William Fletcher Beck | Nasal aromatic releasing compositions |
AU1716995A (en) * | 1994-03-18 | 1995-10-09 | Ciba-Geigy Ag | Aqueous solution of levocabastine for ophthalmic use |
US5698181A (en) * | 1994-12-09 | 1997-12-16 | Warner-Lambert Company | Breath-freshening edible compositions comprising menthol and an N-substituted-P-menthane carboxamide and methods for preparing same |
US5626831A (en) * | 1995-12-20 | 1997-05-06 | Van Moerkerken; Arthur | Method for relief and prevention of common cold, and compositions |
US6469009B1 (en) | 1996-04-08 | 2002-10-22 | Ucb, S.A. | Pharmaceutical compositions for the treatment of rhinitis |
US5891885A (en) * | 1996-10-09 | 1999-04-06 | Algos Pharmaceutical Corporation | Method for treating migraine |
CA2277911C (en) * | 1997-01-13 | 2010-09-14 | Emory University | Compounds and their combinations for the treatment of influenza infection |
GB9707978D0 (en) * | 1997-04-21 | 1997-06-11 | Procter & Gamble | Throat soothing compositions |
GB9707977D0 (en) * | 1997-04-21 | 1997-06-11 | Procter & Gamble | Centre filled confectionery |
DE19814256A1 (de) * | 1998-03-31 | 1999-10-07 | Asta Medica Ag | Feste, schnellzerfallende Cetirizin-Formulierungen |
US6132758A (en) | 1998-06-01 | 2000-10-17 | Schering Corporation | Stabilized antihistamine syrup |
WO2003020258A1 (fr) * | 2001-09-04 | 2003-03-13 | Boehringer Ingelheim International Gmbh | Medicament contre la grippe de type a |
EP1494654B1 (en) | 2002-04-04 | 2008-03-12 | Pfizer Products Inc. | Palatable chewable tablet |
GB2389530B (en) | 2002-06-14 | 2007-01-10 | Cipla Ltd | Pharmaceutical compositions |
US20090203776A1 (en) * | 2004-09-23 | 2009-08-13 | Matias Jonathan R | Methods of using menthol propyleneglycol-carbonate and analogs thereof for producing anti-inflammatory and anti-angiogenic effects |
US10022339B2 (en) | 2006-04-21 | 2018-07-17 | The Procter & Gamble Company | Compositions and methods useful for treatment of respiratory illness |
AU2016219620B2 (en) * | 2006-04-21 | 2017-05-11 | The Procter & Gamble Company | Compositions and methods useful for treatment of respiratory illness |
US20070249727A1 (en) | 2006-04-21 | 2007-10-25 | The Proctor & Gamble Company | Compositions and kits useful for treatment of respiratory illness |
WO2012104569A1 (en) | 2011-02-02 | 2012-08-09 | GILHOLM, Stephen, Philip | Composition of monoterpenoids for the treatment of cancer |
CA3042642A1 (en) | 2013-08-12 | 2015-02-19 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded immediate release abuse deterrent pill |
US9492444B2 (en) | 2013-12-17 | 2016-11-15 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded extended release abuse deterrent pill |
US10172797B2 (en) | 2013-12-17 | 2019-01-08 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded extended release abuse deterrent pill |
JP6371463B2 (ja) | 2014-07-17 | 2018-08-08 | ファーマシューティカル マニュファクチュアリング リサーチ サービシズ,インコーポレーテッド | 即時放出性乱用抑止性液体充填剤形 |
US20160106737A1 (en) | 2014-10-20 | 2016-04-21 | Pharmaceutical Manufacturing Research Services, Inc. | Extended Release Abuse Deterrent Liquid Fill Dosage Form |
WO2019222100A1 (en) | 2018-05-16 | 2019-11-21 | Zumeta Perez Javier | High concentration suspension formulation for cold and flu soft gel capsule medications |
CN112972439A (zh) * | 2019-12-16 | 2021-06-18 | 南京亿华药业有限公司 | 一种愈美泡腾片及其制备方法 |
EP4099977A1 (en) | 2020-02-03 | 2022-12-14 | Johnson & Johnson Consumer Inc. | A single layer chewable tablet comprising cetirizine |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1353381A (en) * | 1971-02-04 | 1974-05-15 | Wilkinson Sword Ltd | Substituted p-menthanes and compositions containing them |
JPS5888334A (ja) * | 1981-11-20 | 1983-05-26 | Takasago Corp | 3−l−メントキシプロパン−1、2−ジオ−ル |
ATE128351T1 (de) * | 1991-04-04 | 1995-10-15 | Procter & Gamble | Essbare pharmazeutische zusammensetzungen zur behandlung von verdauungstraktschmerzen. |
-
1993
- 1993-09-22 CA CA002146637A patent/CA2146637C/en not_active Expired - Fee Related
- 1993-09-22 EP EP93921692A patent/EP0662840A1/en not_active Withdrawn
- 1993-09-22 WO PCT/US1993/008887 patent/WO1994008551A2/en not_active Application Discontinuation
- 1993-09-22 NZ NZ256346A patent/NZ256346A/en unknown
- 1993-09-22 JP JP6510004A patent/JPH08502288A/ja active Pending
- 1993-09-22 AU AU49307/93A patent/AU678561B2/en not_active Ceased
- 1993-10-08 MX MX9306295A patent/MX9306295A/es not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU678561B2 (en) | 1997-06-05 |
WO1994008551A3 (en) | 1994-06-23 |
AU4930793A (en) | 1994-05-09 |
EP0662840A1 (en) | 1995-07-19 |
CA2146637C (en) | 2001-02-13 |
JPH08502288A (ja) | 1996-03-12 |
WO1994008551A2 (en) | 1994-04-28 |
NZ256346A (en) | 1997-04-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9306295A (es) | Composiciones farmaceuticas para tratar sintomas de resfriado. | |
ES2196160T3 (es) | Uso de una combinacion de tensioactivos, agentes quelantes y aceites esenciales para desinfeccion efectiva. | |
FI973492A (fi) | NO-syntaasin estäjät | |
TR200102647T2 (tr) | Doğurganlığı geliştirmeye mahsus bileşimler | |
ATE370730T1 (de) | Pharmazeutische zubereitungen, die chelatbildner/sequestriermittel enthalten und deren dermatologische verwendung | |
NZ505742A (en) | Compositions containing aminobiguanides with antimicrobial activity used to treat contact lenses | |
DE69805983D1 (de) | Hustenhemmende, theobromine enthaltende zusammensetzungen | |
PT752813E (pt) | Inibidores de proteases de parasitas metazoarios | |
MX9505181A (es) | Utilizacion de un antagonista de la substancia p en una composicion farmaceutica para tratar desordenes de la piel de origen neurogenico. | |
EA199800717A1 (ru) | Способ лечения заболеваний млекопитающих и цвиттерионная композиция | |
ECSP930933A (es) | Composicion farmaceutica y procedimiento para prepararla | |
AU5170400A (en) | Topical application of muscarinic and opioid agents for treatment of tinnitus | |
ID24184A (id) | Obat untuk perawatan disfungsi ereksi | |
ES2146249T3 (es) | Composicion farmaceutica para tratar la impotencia que contiene un inhibidor alfa-1 y un inhibidor alfa-2. | |
FI962369A0 (fi) | Farmaseuttinen formulointi myrkytyksen ehkäisemiseksi tai esihoidoksi organofosforisilla koliiniesteraasi-inhibiittoreilla | |
PT1054681E (pt) | Utilizacao de combinacoes de agentes activos consistindo de antibioticos e extractos vegetais contendo terfeno na medicina veterinaria | |
DE69424679D1 (de) | Zusammensetzung zur behandlung oder vorbeugung von herpes | |
ATE200026T1 (de) | Behandlung von laminitis | |
LT96094A (en) | The active ingredient of pharmaceutical composition for treating constipation | |
IT1290910B1 (it) | 2-amminotetralina otticamente attiva, procedimento per la sua preparazione e composizioni farmaceutiche che la contengono, attive | |
DE69114922D1 (de) | Polysulfidverbindungen und Lipidperoxidierungsinhibitore, die diese Polysulfidverbindungen als aktive Zutaten enthalten. | |
BR9608721A (pt) | Composição farmacêutica, e, processo para tratar inflamação | |
UY24181A1 (es) | Método para tratar un infarto de miocardio agudo con hirudina y ácido acetilsalicílico en pacientes no sometidos a tratamiento trombolítico | |
ES2044534T3 (es) | Un metodo para la preparacion de una composicion tromboliticamente activa. | |
ATE271867T1 (de) | Behandlung der harninkontinenz und zusammenstellung dafür |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration | ||
MM | Annulment or lapse due to non-payment of fees |